Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection

Journal of Virology

Volumn 88, Issue 5, 2014, Pages 3004-3015

  Wang, Zhuo ^a   Zhu, Kai ^a   Bai, Weiya ^b   Jia, Baosen ^a   Hu, Hao ^a   Zhou, Dongming ^a   Zhang, Xiaoming ^a   Zhang, Xinxin ^c   Xie, Youhua ^b   Bourgine, Maryline Mancini ^d   Michel, Marie Louise ^d   Lan, Ke ^a   Deng, Qiang ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; EPITOPE; RECOMBINANT HEPATITIS B VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; EFFECTOR CELL; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOTHERAPY; LIVER CELL; MALE; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROGENY; SEROCONVERSION; T LYMPHOCYTE; VIRAL CLEARANCE; VIRION; VIRUS GENOME; VIRUS REPLICATION;

ADENOVIRIDAE; ADMINISTRATION, INTRAVENOUS; ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; EPITOPES; GENE EXPRESSION; GENE ORDER; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; IMMUNIZATION; IMMUNOTHERAPY; LIVER; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, TRANSGENIC; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTE SUBSETS; TRANSDUCTION, GENETIC; VIRAL CORE PROTEINS; VIRION; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 84896705397     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02756-13     Document Type: Article

References (36)

1. Deng Q, Mancini-Bourgine M, Zhang X, Cumont MC, Zhu R, Lone YC, Michel ML. 2009. Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models. Hepatology 50:1380-1391. http://dx.doi.org/10.1002/hep.23150.
2. Asabe S, Wieland SF, Chattopadhyay PK, Roederer M, Engle RE, Purcell RH, Chisari FV. 2009. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J. Virol. 83:9652-9662. http: //dx.doi.org/10.1128/JVI.00867-09.
3. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829. http://dx.doi.org/10.1126/science .284.5415.825.
4. Guo JT, Zhou H, Liu C, Aldrich C, Saputelli J, Whitaker T, Barrasa MI, Mason WS, Seeger C. 2000. Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections. J. Virol. 74:1495-1505. http://dx.doi.org/10.1128/JVI.74.3.1495-1505.2000.
5. Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, Chisari FV. 2003. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77:68-76. http://dx.doi.org/10.1128/JVI.77.1.68-76.2003.
6. Zhu Y, Yamamoto T, Cullen J, Saputelli J, Aldrich CE, Miller DS, Litwin S, Furman PA, Jilbert AR, Mason WS. 2001. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J. Virol. 75:311-322. http://dx.doi.org/10.1128/JVI.75.1.311-322.2001.
7. Nuriya H, Inoue K, Tanaka T, Hayashi Y, Hishima T, Funata N, Kaji K, Hayashi S, Kaneko S, Kohara M. 2010. Detection of hepatitis B and C viruses in almost all hepatocytes by modified PCR-based in situ hybridization. J. Clin. Microbiol. 48:3843-3851. http://dx.doi.org/10.1128/JCM .00415-10.
8. Wieland SF, Chisari FV. 2005. Stealth and cunning: hepatitis B and hepatitis C viruses. J. Virol. 79:9369-9380. http://dx.doi.org/10.1128/JVI .79.15.9369-9380.2005.
9. Huang LR, Gabel YA, Graf S, Arzberger S, Kurts C, Heikenwalder M, Knolle PA, Protzer U. 2012. Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice. Gastroenterology 142:1447-1450. http://dx.doi.org/10.1053 /j.gastro.2012.03.006.
10. Shayakhmetov DM, Li ZY, Ni S, Lieber A. 2004. Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors. J. Virol. 78:5368-5381. http://dx .doi.org/10.1128/JVI.78.10.5368-5381.2004.
11. Godfrey DI, Uldrich AP, Baxter AG. 2012. NKT cells-an early warning system for HBV infection. Nat. Med. 18:1014-1016. http://dx.doi.org/10 .1038/nm.2853.
12. Tatsis N, Fitzgerald JC, Reyes-Sandoval A, Harris-McCoy KC, Hensley SE, Zhou D, Lin SW, Bian A, Xiang ZQ, Iparraguirre A, Lopez-Camacho C, Wherry EJ, Ertl HC. 2007. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood 110:1916-1923. http://dx.doi.org/10.1182/blood-2007-02-062117.
13. Finn JD, Bassett J, Millar JB, Grinshtein N, Yang TC, Parsons R, Evelegh C, Wan Y, Parks RJ, Bramson JL. 2009. Persistence of transgene expression influences CD8+T-cell expansion and maintenance following immunization with recombinant adenovirus. J. Virol. 83:12027-12036. http://dx.doi.org/10.1128/JVI.00593-09.
14. Bassett JD, Swift SL, Bramson JL. 2011. Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors. Expert Rev. Vaccines 10:1307-1319. http://dx.doi.org/10.1586/erv.11.88.
15. Dong XY, Yu CJ, Wang G, Tian WH, Lu Y, Zhang FW, Wang W, Wang Y, Tan WJ, Wu XB. 2010. Establishment of hepatitis B virus (HBV) chronic infection mouse model by in vivo transduction with a recombinant adeno-associated virus 8 carrying 1.3 copies of HBV genome (rAAN8-1.3HBV). Bing Du Xue Bao 26:425-431. (In Chinese.)
16. Bayard F, Malmassari S, Deng Q, Lone YC, Michel ML. 2010. Hepatitis B virus (HBV)-derived DRB1*0101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+T cells in vivo. Vaccine 28:3818-3826. http://dx.doi.org/10.1016/j.vaccine.2010.03.026.
17. Walter E, Keist R, Niederost B, Pult I, Blum HE. 1996. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 24:1-5. http://dx.doi.org/10.1002/hep.510240101.
18. Hong R, Bai W, Zhai J, Liu W, Li X, Zhang J, Cui X, Zhao X, Ye X, Deng Q, Tiollais P, Wen Y, Liu J, Xie Y. 2013. Novel recombinant hepatitis B virus vectors efficiently deliver protein and RNA encoding genes into primary hepatocytes. J. Virol. 87:6615-6624. http://dx.doi.org /10.1128/JVI.03328-12.
19. Isogawa M, Kakimi K, Kamamoto H, Protzer U, Chisari FV. 2005. Differential dynamics of the peripheral and intrahepatic cytotoxic T lymphocyte response to hepatitis B surface antigen. Virology 333:293-300. http://dx.doi.org/10.1016/j.virol.2005.01.004.
20. Sells MA, Zelent AZ, Shvartsman M, Acs G. 1988. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J. Virol. 62:2836-2844.
21. Uprichard SL, Wieland SF, Althage A, Chisari FV. 2003. Transcriptional and posttranscriptional control of hepatitis B virus gene expression. Proc. Natl. Acad. Sci. U. S. A. 100:1310-1315. http://dx.doi.org/10.1073/pnas .252773599.
22. Wieland SF, Eustaquio A, Whitten-Bauer C, Boyd B, Chisari FV. 2005. Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc. Natl. Acad. Sci. U. S. A. 102:9913-9917. http://dx.doi.org/10.1073/pnas.0504273102.
23. Xu C, Guo H, Pan XB, Mao R, Yu W, Xu X, Wei L, Chang J, Block TM, Guo JT. 2010. Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus. J. Virol. 84:9332-9340. http://dx.doi.org /10.1128/JVI.00918-10.
24. Puro R, Schneider RJ. 2007. Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA. J. Virol. 81:7351-7362. http://dx.doi .org/10.1128/JVI.00554-07.
25. Belloni L, Allweiss L, Guerrieri F, Pediconi N, Volz T, Pollicino T, Petersen J, Raimondo G, Dandri M, Levrero M. 2012. IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J. Clin. Invest. 122:529-537. http://dx.doi .org/10.1172/JCI58847.
26. Guidotti LG, Chisari FV. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:65-91. http://dx.doi.org/10.1146/annurev.immunol.19.1.65.
27. Chisari FV. 2000. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am. J. Pathol. 156:1117-1132. http://dx .doi.org/10.1016/S0002-9440(10)64980-2.
28. Feld J, Lee JY, Locarnini S. 2003. New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38:545-553. http://dx.doi.org/10.1053/jhep.2003.50389.
29. Melegari M, Wolf SK, Schneider RJ. 2005. Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression. J. Virol. 79:9810-9820. http://dx.doi.org/10.1128/JVI.79.15 .9810-9820.2005.
30. Ni Y, Sonnabend J, Seitz S, Urban S. 2010. The pre-s2 domain of the hepatitis B virus is dispensable for infectivity but serves a spacer function for L-protein-connected virus assembly. J. Virol. 84:3879-3888. http://dx .doi.org/10.1128/JVI.02528-09.
31. von Freyend MJ, Untergasser A, Arzberger S, Oberwinkler H, Drebber U, Schirmacher P, Protzer U. 2011. Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B. J. Viral Hepat. 18: 216-226. http://dx.doi.org/10.1111/j.1365-2893.2010.01302.x.
32. Holst PJ, Orskov C, Thomsen AR, Christensen JP. 2010. Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination. J. Immunol. 184:4431-4439. http://dx.doi.org/10.4049/jimmunol .0900537.
33. Wherry EJ, Ahmed R. 2004. Memory CD8 T-cell differentiation during viral infection. J. Virol. 78:5535-5545. http://dx.doi.org/10.1128/JVI.78 .11.5535-5545.2004.
34. Mancini-Bourgine M, Fontaine H, Scott-Algara D, Pol S, Brechot C, Michel ML. 2004. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Hepatology 40:874-882. http://dx.doi.org/10.1002/hep.20408.
35. Michel ML, Deng Q, Mancini-Bourgine M. 2011. Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges. J. Hepatol 54:1286-1296. http://dx.doi.org /10.1016/j.jhep.2010.12.031.
36. Dion S, Bourgine M, Godon O, Levillayer F, Michel ML. 2013. Adenoassociated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules. J. Virol. 87:5554-5563. http://dx.doi.org/10.1128/JVI.03134-12.